Abstract:Transient receptor potential canonical channels (TRPCs) are calcium-permeable, nonselective cation channels. Human TRPC channels contain six functional members: TRPC1, and TRPC3-7, and they are widely distributed in many tissues. These channels are involved in numerous physiological processes, including regulating myogenic tone and blood pressure, endothelial barrier function regulation, hypoxic pulmonary vasoconstriction, neuronal function, and kidney function. They are also associated with several diseases, including traumatic brain injury, pathologic cardiac hypertrophy, atherosclerosis, the development of cancer, and diabetes. Specifically, gain-of-function mutations of the TRPC6 gene in humans cause focal segmental glomerular sclerosis (FSGS), a chronic kidney disease for which there is no effective treatment. Consequently, TRPC channels serve as drug targets for several diseases, including FSGS and anxiety. Recent developments in single-particle cryo-EM permit the determination of the structures of multiple TRPC channel members (TRPC3, TRPC4, TRPC5, and TRPC6) in multiple states at near-atomic resolutions. These structures demonstrate that TRPC channels are tetramers composed of two layers: The upper transmembrane domain (TMD) and the lower intracellular domain (ICD). The ICD layer consists of ankyrin repeat domains (ARD), linker helices domains (LHD), the TRP helix, and C terminal helices. The four protomers' voltage sensor-like domains (VSLD) and pore domains form the TMD layer. ICD has a bell-like shape with a large central chamber and caps below TMD. The structures reveal both the inhibitory calcium binding site in ICD and the activating calcium binding site in TMD. Calcium binding to the inhibitory site results in the closure of the ICD and the restriction of ion flow through the ICD, whereas calcium dissociation from the inhibitory site results in the opening of the ICD and the unrestricted flow of ions through the ICD. Calcium binding to the activating site increases its activity. Additionally, the binding pockets and binding poses of several small molecule modulators of TRPC channels are identified. Their binding sites are distributed across three distinct regions of TMD. One of the pockets partially overlaps the endogenous activating lipid diacylglycerol-binding site, while another partially overlaps the activating calcium-binding site. In conclusion, these structural findings combined with functional analysis, particularly site-directed mutagenesis data, reveal how intracellular calcium concentrations bi-directionally modulate the TRPC channel, how small molecules bind and tune the activity of TRPC channels, and how the gain-of-function mutations found in FSGS patients over-activate the intracellular calcium signaling of kidney podocytes via the TRPC6 channel in a positive feedback manner. These developments lay the groundwork for a more in-depth mechanistic dissection of TRPC channels. They would also facilitate the discovery of drugs that target TRPC channels to treat associated diseases.

Small molecules targeting canonical transient receptor potential channels: an update

Trpc Channels: Structure, Function, Regulation And Recent Advances In Small Molecular Probes

Selective Inhibition of TRPM2 Channel by Two Novel Synthesized ADPR Analogues

Targeting TRP channels: recent advances in structure, ligand binding, and molecular mechanisms

Canonical Transient Receptor Potential Channels and Their Link with Cardio/Cerebro-Vascular Diseases

Natural modulators of transient receptor potential channels

Pathophysiological significance and modulation of the transient receptor potential canonical 3 ion channel

Canonical Transient Receptor Potential (TRPC) Channels in Cardiovascular Pathology and their Modulators

Advances in the structural mechanism of TRPC channels

TRP (transient receptor potential) ion channel family: structures, biological functions and therapeutic interventions for diseases

Targeting Transient Receptor Potential Canonical Channels for Diseases of the Nervous System.

Identification and Optimization of 2‐aminobenzimidazole Derivatives As Novel Inhibitors of TRPC4 and TRPC5 Channels

Pyrazolopyrimidines As Potent Stimulators for Transient Receptor Potential Canonical 3/6/7 Channels.

Transient receptor potential channels in cardiac health and disease

Transient receptor potential ankyrin 1 (TRPA1) modulators: Recent update and future perspective

Structure of the Receptor-Activated Human TRPC6 and TRPC3 Ion Channels

TRP channels: an overview

Discovery of potential novel TRPC5 inhibitors by virtual screening and bioassay

Transient receptor proteins illuminated: current views on TRPs and disease

TR(i)P Goes On: Auxiliary TRP Channel Subunits?

Transient receptor potential canonical type 3 channels: Interactions, role and relevance - A vascular focus